[1]沈雪梅.齐拉西酮与奥氮平治疗首发精神分裂症 疗效及糖脂代谢的影响观察[J].医学信息,2018,31(06):130-132.[doi:10.3969/j.issn.1006-1959.2018.06.044]
　SHEN XUE-mei.The Effect of Ziprasidone and Olanzapine in the Treatment of First Episode Schizophrenia and the Effect of Glycolipid Metabolism[J].Journal of Medical Information,2018,31(06):130-132.[doi:10.3969/j.issn.1006-1959.2018.06.044]
点击复制

齐拉西酮与奥氮平治疗首发精神分裂症 疗效及糖脂代谢的影响观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年06期
页码:
130-132
栏目:
药物与临床
出版日期:
2018-03-20

文章信息/Info

Title:
The Effect of Ziprasidone and Olanzapine in the Treatment of First Episode Schizophrenia and the Effect of Glycolipid Metabolism
文章编号:
1006-1959（2018）06-0130-03
作者:
沈雪梅
宣城市第四人民医院门诊药房，安徽 宣城 242000
Author(s):
SHEN XUE-mei
Outpatient Pharmacy of the Fourth People's Hospital in Xuancheng,Xuancheng 242000,Anhui,China
关键词:
齐拉西酮; 奥氮平; 精神分裂症; 糖脂代谢
Keywords:
Key words：Ziprasidone; Olanzapine; Schizophrenia; Glucose and lipid metabolism
分类号:
R749.3
DOI:
10.3969/j.issn.1006-1959.2018.06.044
文献标志码:
A
摘要:
目的 研究齐拉西酮与奥氮平治疗首发精神分裂症疗效及用药后对患者机体糖脂代谢的影响。方法 选取我院精神病科2016年1月~2017年5月收治并接受治疗的精神分裂症患者68例，随机分为对照组和观察组，每组34例。观察组采用齐拉西酮进行治疗，对照组采用奥氮平进行治疗，对比两组患者临床疗效、FBG、TG、LDL-C、HDL-C、TC的变化情况，以及不良反应情况。结果 两组患者治疗有效率均为88.20%，差异无统计学意义（P＞0.05）；对照组患者血清总胆固醇（TC）、血糖（FBG）分别为（4.62±0.31）mmol/L、（5.67±0.29）mmol/L，高于观察组的（3.91±0.28）mmol/L、（5.13±0.35）mmol/L，差异具有统计学意义（P＜0.05）。治疗后两组患者FBG、TG、LDL-C、HDL-C、TC指标均有一定程度变化，其中观察组患者三酰甘油（TG）为（1.25±0.35）mmol/L，高于对照组的（0.84±0.37）mmol/L，差异具有统计学意义（P＜0.05）。观察组患者服药后出现较为明显的震颤情况，震颤比例26.47%，高于对照组患者的8.82%，差异具有统计学意义（P＜0.05）。结论 齐拉西酮与奥氮平治疗首发精神分裂症疗效基本一致，糖脂代谢及不良反应具有一定差异，在临床应结合患者实际情况选择合适的治疗方案，以便患者病情的康复及减少不良反应发生。
Abstract:
Abstract：Objective To study the efficacy of ziprasidone and olanzapine in the treatment of first-episode schizophrenia and the effects of ziprasidone and olanzapine on glucose and lipid metabolism.Methods In our hospital psychiatric department in January 2016 to 2017 year in May 68 cases of schizophrenia patients were treated and randomly divided into control group and observation group,with 34 cases in each group.The observation group received ziprasidone treatment,the control group were treated with olanzapine,clinical curative effect,compared with two groups of FBG,TG,LDL-C,HDL-C.The change of TC, and adverse reacts.Results The effective rate of treatment in both groups was 88.20%,the difference was not significant(P>0.05),the serum total cholesterol(TC) and blood glucose(FBG)in the control group were(4.62±0.31)mmol/L and(5.67±0.29)mmol/L,respectively,which were higher than those in the observation group(3.91±0.28)mmol/L and(5.13±0.35)mmol/L,the difference was statistically significant(P<0.05).After treatment,the FBG,TG,LDL-C,HDL-C and TC indexes of the two groups changed to some extent.The three glycerol(TG)in the observation group was(1.25±0.35)mmol/L, which was higher than that in the control group(0.84±0.37)mmol/L,the difference was statistically significant(P<0.05).The patients in the observation group had a more obvious tremor after taking medicine,and the proportion of tremors was 26.47%,which was higher than that in the control group(8.82%).The difference was statistically significant(P<0.05).Conclusion The efficacy of ziprasidone and olanzapine in the treatment of first-episode schizophrenia is basically the same.There are certain differences between glucose and lipid metabolism and adverse reactions.In clinical practice,we should choose the appropriate treatment plan according to the actual situation of patients,so as to restore the patient's condition and reduce the incidence of adverse reactions.

参考文献/References:

[1]杨力,王盟,顾冬云,等.小剂量喹硫平联合齐拉西酮对女性精神分裂症患者的疗效及体质量、血清泌乳素水平的变化观察[J].国际精神病学杂志,2017,44(04):605-607. [2]赵丽,冯竹娥,盛玉霞.齐拉西酮联合低剂量喹硫平治疗女性首发精神分裂症临床观察[J].现代中西医结合杂志,2017,26(24):2692-2694. [3]晏鑫鹏,饶莹.齐拉西酮治疗精神分裂症的应用效果评估及研究[J].当代医学,2017,23(25):34-36. [4]王蓉.齐拉西酮联用艾司西酞普兰治疗伴发抑郁症状精神分裂患者的安全性及其疗效[J].世界最新医学信息文摘,2017,17(65):107. [5]高立新.齐拉西酮-新型非典型抗精神病药物应用研究[J].中国现代药物应用,2013,7(20):20-21. [6]王敬龙,李斌,何金华.齐拉西酮与利培酮治疗老年期精神分裂症的疗效观察[J].中国健康心理学杂志,2012,20(05):663-664. [7]柴志宏.齐拉西酮治疗精神分裂症患者的疗效及对其生活质量的作用探讨[J].当代医学,2017,23(15):32-34. [8]朱虹,贾竑晓,阎爱国,等.齐拉西酮治疗精神分裂症疗效及不良反应的相关因素分析[J].首都医科大学学报,2016,27(02):164-167. [9]刘富会.齐拉西酮与利培酮治疗精神分裂症的临床研究[J].精神医学杂志,2015,28(06):457-459. [10]梁红蕾.阿立哌唑联合齐拉西酮治疗精神分裂症疗效观察[J].精神医学杂志,2015,28(04):293-294.

相似文献/References:

[1]鲁从林,王先丹,杨遂平,等.奥氮平治疗老年痴呆伴精神行为障碍的临床疗效观察[J].医学信息,2018,31(01):138.[doi:10.3969/j.issn.1006-1959.2018.01.053]
　LU Cong-lin,WANG Xian-dan,YANG Sui-ping,et al.The Clinical Efficacy of Olanzapine in the Treatment of Alzheimer's Disease with Mental Behavior Disorder[J].Journal of Medical Information,2018,31(06):138.[doi:10.3969/j.issn.1006-1959.2018.01.053]
[2]蔡 枫,姚雪阳.利培酮与奥氮平治疗酒精所致精神和行为障碍的临床研究[J].医学信息,2018,31(03):137.[doi:10.3969/j.issn.1006-1959.2018.03.048]
　CAI Feng,YAO Xue-yang.Clinical Study of Risperidone and Olanzapine in the Treatment of Alcohol-induced Mental and Behavioral Disorders[J].Journal of Medical Information,2018,31(06):137.[doi:10.3969/j.issn.1006-1959.2018.03.048]
[3]黄美英,符 奇.奥氮平与阿立哌唑治疗首发精神分裂症的效果及其对患者认知功能的影响[J].医学信息,2020,33(21):149.[doi:10.3969/j.issn.1006-1959.2020.21.046]
　HUANG Mei-ying,FU Qi.The Effect of Olanzapine and Aripiprazole in the Treatment of First-episode Schizophrenia and Its Influence on Patients’ Cognitive Function[J].Journal of Medical Information,2020,33(06):149.[doi:10.3969/j.issn.1006-1959.2020.21.046]
[4]吴 鹏.坦度螺酮联合奥氮平对精神分裂症患者认知功能的影响[J].医学信息,2021,34(16):9.[doi:10.3969/j.issn.1006-1959.2021.16.003]
　WU Peng.The Effect of Tandospirone Combined with Olanzapine on the Cognitive Function of Patients with Schizophrenia[J].Journal of Medical Information,2021,34(06):9.[doi:10.3969/j.issn.1006-1959.2021.16.003]
[5]刘 兵.齐拉西酮与奥氮平治疗早期精神分裂症的疗效[J].医学信息,2020,33(03):136.[doi:10.3969/j.issn.1006-1959.2020.03.042]
　LIU Bing.Efficacy of Ziprasidone and Olanzapine in Early Schizophrenia[J].Journal of Medical Information,2020,33(06):136.[doi:10.3969/j.issn.1006-1959.2020.03.042]

更新日期/Last Update: 2018-03-15